Cargando…
ODP132 Efficacy of Romosozumab for Osteoporosis in a Patient with Hajdu-Cheney Syndrome: A Case Report
INTRODUCTION: Hajdu–Cheney syndrome (HCS) is a genetic disease with an autosomal-dominant pattern caused by mutations of NOTCH2. This rare disease primarily causes skeletal dysplasia, including craniofacial dysmorphology, dental anomalies, and short stature accompanied by radiographic abnormalities...
Autores principales: | Kim, Kyoung Jin, Rhee, Yumie, Hong, Namki, Lee, Seunghyun, Shin, Sungjae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624654/ http://dx.doi.org/10.1210/jendso/bvac150.373 |
Ejemplares similares
-
ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022) -
ODP104 Isolated familial hypoparathyroidism with Tbx1 mutation in Korea
por: Lee, Seunghyun, et al.
Publicado: (2022) -
OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023) -
ODP077 Adipopenia is associated with low bone mass in community-dwelling non-underweight adults, independent of sarcopenia
por: Lee, Seunghyun, et al.
Publicado: (2022) -
Circulating Lipocalin-2 Predicts Changes in Lumbar Spine Bone Mineral Density After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)